Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

The use of targeted agents in the treatment of metastatic colorectal cancer (CRC) has improved patient outcomes. Anti-epidermal growth factor receptor (anti-EGFR) agents (cetuximab and panitumumab) and antiangiogenic molecules (bevacizumab, regorafeninb, ramucirumab, and aflibercept) have been succe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bignucolo, Alessia, De Mattia, Elena, Cecchin, Erika, Roncato, Rossana, Toffoli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536012/
https://www.ncbi.nlm.nih.gov/pubmed/28708103
http://dx.doi.org/10.3390/ijms18071522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536012/
https://www.ncbi.nlm.nih.gov/pubmed/28708103
http://dx.doi.org/10.3390/ijms18071522

Ejemplares similares